1. |
贾雪莹, 巩丽, 张伟. 重症肌无力病因学及发病机制的研究进展. 细胞与分子免疫学杂志, 2021, 37(4): 368-372.
|
2. |
莫建义. 重症肌无力病因、发病机制、分子靶向治疗研究进展. 卒中与神经疾病, 2017, 24(3): 262-264, 270.
|
3. |
张华, 闻洁曦. 重症肌无力不是指严重的肌无力. 中国神经免疫学和神经病学杂志, 2019, 26(4): 310-312.
|
4. |
黄一铿, 黄嘉正, 曾辰林, 等. 重症肌无力的发病机制. 生命的化学, 2021, 41(11): 2327-2333.
|
5. |
罗苏珊, 奚才华, 杨磊, 等. 重症肌无力危象多学科协作的华山经验. 中国临床神经科学, 2023, 31(5): 550-557.
|
6. |
Stojanov A, Milošević V, Đorđević G, et al. Quality of life of myasthenia gravis patients in regard to epidemiological and clinical characteristics of the disease. Neurologist, 2019, 24(4): 115-120.
|
7. |
Liu C, Li T, Wang Q, et al. Post-traumatic stress disorder symptoms after respiratory insufficiency in patients with myasthenia gravis. Psychol Health Med, 2021, 26(2): 221-227.
|
8. |
Mathews EP, Romito JW. Management of immune checkpoint inhibitor-related acute hypoxic neuromuscular respiratory failure using high-flow nasal cannula. Proc (Bayl Univ Med Cent), 2020, 33(3): 407-408.
|
9. |
Braz NFT, Rocha NP, Vieira ÉLM, et al. Body composition and adipokines plasma levels in patients with myasthenia gravis treated with high cumulative glucocorticoid dose. J Neurol Sci, 2017, 381: 169-175.
|
10. |
Chang CC, Chen YK, Chiu HC, et al. Assessment of sarcopenia and obesity in patients with myasthenia gravis using dual-energy X-ray absorptiometry: a cross-sectional study. J Pers Med, 2021, 11(11): 1139.
|
11. |
Sekula P, Del Greco M F, Pattaro C, et al. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol, 2016, 27(11): 3253-3265.
|
12. |
Taschler B, Smith SM, Nichols TE. Causal inference on neuroimaging data with Mendelian randomisation. Neuroimage, 2022, 258: 119385.
|
13. |
Boehm FJ, Zhou X. Statistical methods for Mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J, 2022, 20: 2338-2351.
|
14. |
王浩桦, 丁子琛, 包绮晗, 等. 基于孟德尔随机化的血脂六项与冠心病因果关系研究. 现代预防医学, 2023, 50(10): 1736-1742, 1753.
|
15. |
Xu Y, Guo Y. Platelet indices and blood pressure: a multivariable Mendelian randomization study. Thromb J, 2023, 21(1): 31.
|
16. |
蔚文锴, 史长河, 史晶晶, 等. 慢性阻塞性肺疾病与脑小血管病的孟德尔随机化研究. 中国实用神经疾病杂志, 2022, 25(3): 316-319.
|
17. |
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol, 2015, 44(2): 512-525.
|
18. |
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol, 2017, 32(5): 377-389.
|
19. |
徐铭培. 阿司匹林使用与乳腺癌及皮肤癌之间的关系: 一项孟德尔随机化研究. 济南: 山东大学, 2022.
|
20. |
Golfinopoulou R, Papageorgiou L, Efthimiadou A, et al. Clinical genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with myasthenia gravis (review). Molecul Med Rep, 2021, 24(1): 1-9.
|
21. |
Gilhus NE. Myasthenia gravis. N Engl J Med, 2016, 375(26): 2570-2581.
|
22. |
Fardet L, Cabane J, Kettaneh A, et al. Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology (Oxford), 2007, 46(7): 1102-1106.
|
23. |
Fasshauer M, Blüher M. Adipokines in health and disease. Trend Pharmacol Sci, 2015, 36(7): 461-470.
|
24. |
Szczudlik P, Sobieszczuk E, Szyluk B, et al. Determinants of quality of life in myasthenia gravis patients. Front Neurol, 2020, 11: 553626.
|
25. |
秦雪英, 陈大方, 胡永华. 孟德尔随机化方法在流行病学病因推断中的应用. 中华流行病学杂志, 2006, 27(7): 630-633.
|
26. |
刘娅飞. 基于孟德尔随机化探索代谢综合征相关指标间因果关系的研究. 济南: 山东大学, 2018.
|